1070 related articles for article (PubMed ID: 31707800)
21. Outcomes After Continuous-Flow Left Ventricular Assist Device Implantation as Destination Therapy at Transplant Versus Nontransplant Centers.
Brinkley DM; DeNofrio D; Ruthazer R; Vest AR; Kapur NK; Couper GS; Kiernan MS
Circ Heart Fail; 2018 Mar; 11(3):e004384. PubMed ID: 29540471
[TBL] [Abstract][Full Text] [Related]
22. Preimplant Phosphodiesterase-5 Inhibitor Use Is Associated With Higher Rates of Severe Early Right Heart Failure After Left Ventricular Assist Device Implantation.
Gulati G; Grandin EW; Kennedy K; Cabezas F; DeNofrio DD; Kociol R; Rame JE; Pagani FD; Kirklin JK; Kormos RL; Teuteberg J; Kiernan M
Circ Heart Fail; 2019 Jun; 12(6):e005537. PubMed ID: 31181953
[TBL] [Abstract][Full Text] [Related]
23. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
Stewart GC; Kittleson MM; Patel PC; Cowger JA; Patel CB; Mountis MM; Johnson FL; Guglin ME; Rame JE; Teuteberg JJ; Stevenson LW
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27834198
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary Arterial Elastance and INTERMACS-Defined Right Heart Failure Following Left Ventricular Assist Device.
Muslem R; Ong CS; Tomashitis B; Schultz J; Ramu B; Craig ML; Van Bakel AB; Gilotra NA; Sharma K; Hsu S; Whitman GJ; Leary PJ; Cogswell R; Lozonschi L; Houston BA; Zijlstra F; Caliskan K; Bogers AJJC; Tedford RJ
Circ Heart Fail; 2019 Aug; 12(8):e005923. PubMed ID: 31401840
[TBL] [Abstract][Full Text] [Related]
25. Limited Utility of Tricuspid Valve Repair at the Time of Left Ventricular Assist Device Implantation.
Song HK; Gelow JM; Mudd J; Chien C; Tibayan FA; Hollifield K; Naftel D; Kirklin J
Ann Thorac Surg; 2016 Jun; 101(6):2168-74. PubMed ID: 27139368
[TBL] [Abstract][Full Text] [Related]
26. A Novel Extracorporeal Continuous-Flow Ventricular Assist System for Patients With Advanced Heart Failure - Initial Clinical Experience.
Seguchi O; Fujita T; Kitahata N; Iwasaki K; Kuroda K; Nakajima S; Watanabe T; Yanase M; Fukushima S; Tsukiya T; Katagiri N; Mizuno T; Takewa Y; Hamasaki T; Onda K; Hayashi T; Yamamoto H; Tatsumi E; Kobayashi J; Fukushima N
Circ J; 2020 Jun; 84(7):1090-1096. PubMed ID: 32461539
[TBL] [Abstract][Full Text] [Related]
27. Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure.
Tang PC; Haft JW; Romano MA; Bitar A; Hasan R; Palardy M; Wu X; Aaronson KD; Pagani FD
J Thorac Cardiovasc Surg; 2020 Mar; 159(3):897-905.e4. PubMed ID: 31101350
[TBL] [Abstract][Full Text] [Related]
28. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
[TBL] [Abstract][Full Text] [Related]
29. Predicting the Risk of Right Ventricular Failure in Patients Undergoing Left Ventricular Assist Device Implantation: A Systematic Review.
Frankfurter C; Molinero M; Vishram-Nielsen JKK; Foroutan F; Mak S; Rao V; Billia F; Orchanian-Cheff A; Alba AC
Circ Heart Fail; 2020 Oct; 13(10):e006994. PubMed ID: 32981331
[TBL] [Abstract][Full Text] [Related]
30. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
[TBL] [Abstract][Full Text] [Related]
31. Factors Associated With Health-Related Quality of Life 2 Years After Left Ventricular Assist Device Implantation: Insights From INTERMACS.
Grady KL; Fazeli PL; Kirklin JK; Pamboukian SV; White-Williams C
J Am Heart Assoc; 2021 Jul; 10(14):e021196. PubMed ID: 34238018
[TBL] [Abstract][Full Text] [Related]
32. Preliminary Experience of Extracorporeal Cytokine Hemoadsorption during Left Ventricular Assist Device Implantation in Cardiogenic Shock Patients.
Pausch J; Mersmann J; Bhadra OD; Barten MJ; Alassar YA; Schulte-Uentrop L; Reichenspurner H; Bernhardt AM
Thorac Cardiovasc Surg; 2024 Jun; 72(4):266-272. PubMed ID: 36216331
[TBL] [Abstract][Full Text] [Related]
33. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
Noly PE; Kirsch M; Quessard A; Leger P; Pavie A; Amour J; Leprince P
Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation.
Kang G; Ha R; Banerjee D
J Heart Lung Transplant; 2016 Jan; 35(1):67-73. PubMed ID: 26212656
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of venopulmonary arterial extracorporeal life support as temporary right ventricular support after left ventricular assist implantation.
Shehab S; Rao S; Macdonald P; Newton PJ; Spratt P; Jansz P; Hayward CS
J Thorac Cardiovasc Surg; 2018 Dec; 156(6):2143-2152. PubMed ID: 30025607
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Asian-Americans Implanted With Left Ventricular Assist Devices: An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Analysis.
Taleb I; Wever-Pinzon J; Wang W; Koliopoulou A; Dranow E; Yu T; Yin L; McKellar SH; Stehlik J; Fang JC; Wever-Pinzon O; Selzman CH; Drakos SG
Heart Lung Circ; 2020 Aug; 29(8):1226-1233. PubMed ID: 32085955
[TBL] [Abstract][Full Text] [Related]
37. Are biventricular assist devices underused as a bridge to heart transplantation in patients with a high risk of postimplant right ventricular failure?
Bartfay SE; Dellgren G; Lidén H; Holmberg M; Gäbel J; Redfors B; Bech-Hanssen O; Karason K
J Thorac Cardiovasc Surg; 2017 Feb; 153(2):360-367.e1. PubMed ID: 27955912
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and outcome of ambulatory heart failure patients receiving a left ventricular assist device.
Baudry G; Nesseler N; Flecher E; Vincentelli A; Goeminne C; Delmas C; Porterie J; Nubret K; Pernot M; Kindo M; Hoang Minh T; Rouvière P; Gaudard P; Michel M; Senage T; Boignard A; Chavanon O; Para M; Verdonk C; Pelcé E; Gariboldi V; Anselme F; Litzler PY; Blanchart K; Babatasi G; Bielefeld M; Bouchot O; Hamon D; Lellouche N; Bailleul X; Genet T; Eschalier R; d'Ostrevy N; Bories MC; Akar RA; Blangy H; Vanhuyse F; Obadia JF; Galand V; Pozzi M
ESC Heart Fail; 2021 Dec; 8(6):5159-5167. PubMed ID: 34494391
[TBL] [Abstract][Full Text] [Related]
39. Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn-Columbia Risk Score.
Birati EY; Hanff TC; Maldonado D; Grandin EW; Kennel PJ; Mazurek JA; Vorovich E; Seigerman M; Howard JLL; Acker MA; Naka Y; Wald J; Goldberg LR; Jessup M; Atluri P; Margulies KB; Schulze PC; Rame JE
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514805
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and utility of intraoperative epicardial scar characterization during left ventricular assist device implantation.
Moss JD; Oesterle A; Raiman M; Flatley EE; Beaser AD; Jeevanandam V; Klein L; Ota T; Wieselthaler G; Uriel N; Tung R
J Cardiovasc Electrophysiol; 2019 Feb; 30(2):183-192. PubMed ID: 30516301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
